This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
3/7/2022
Ashley
Conference Operator
We appreciate your patience. Please continue to stand by. Mm-hmm. Thank you. We appreciate your patience. Please continue to standby. Thank you. Thank you. Thank you. Thank you. Thank you. We appreciate your patience.
Unidentified Announcement
Standby Message
Please continue to stand by. Thank you.
Ashley
Conference Operator
Please stand by. Your program is about to begin. If you should need any audio assistance during your call today, please press star and zero. Good morning, everyone. My name is Ashley, and I'll be your conference operator. At this time, I'd like to welcome everyone to the Eagle Pharmaceuticals fourth quarter and full year 2021 financial results. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question and answer period. At that time, if you have a question, please press star and 1 on your telephone keypad. As a reminder, this conference call is being recorded today, March 7, 2022. It is now my pleasure to turn the floor over to Ms. Lisa Wilson, Investor Relations for Eagle Pharmaceuticals. Please go ahead.
You're reading a preview of the EGRX Q4 2021 earnings call.
Free account.
Disclaimer